Genetic testing for cancer risk in young women
Part of Cancer clinical trials.
This study offers free genetic testing to women ages 25-39 who receive gynecologic care at certain NYU Langone Health clinics. The goal is to find inherited gene changes that may increase risk for ovarian and related cancers, so you can take steps to reduce your risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 39 years old
- You get your gynecologic care at one of the listed NYU Langone Health locations
- You have never had ovarian, fallopian tube, primary peritoneal, or uterine cancer
- You have not had genetic testing for ovarian cancer risk before (home saliva kits like 23andMe are okay)
- You have not had both ovaries and fallopian tubes removed
- You are not pregnant or within 2 weeks of giving birth at the time of your visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers free genetic testing to Black or African American people who have had certain cancers. It aims to find inherited gene changes that increase cancer risk and improve health equity.
This study helps people with cancer learn about genetic testing for hereditary cancer. It aims to improve access to testing and support for those who may have an inherited risk.
This study helps prostate cancer survivors get genetic testing for inherited cancer risk. It aims to make testing easier to access and understand.
This study tests a new online way to offer genetic testing and counseling for people concerned about hereditary cancer. It aims to make it easier and faster to access these services from home.
This study tests a program that helps primary care doctors identify women who may benefit from genetic testing for hereditary breast and ovarian cancer. The program uses family history to guide testing and aims to make it easier for patients to get tested.
This study looks for new ways to lower the risk of colorectal and endometrial cancers. It collects tissue and information from people who are getting certain procedures or treatments at Weill Cornell Medicine.
Hear when a new Genetic Testing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.